DENNIS BRODSKY: Open Payments
NPI 1235649039 · OCEANSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,199 in 87 payments from 21 companies in 2025. Trend: 2023 $2,712 · 2024 $2,286 · 2025 $2,199
Food & beverage: $2,199
| Company | Payments | Amount |
|---|---|---|
| Saluda Medical Americas, Inc. | 8 | $438 |
| Collegium Pharmaceutical, Inc. | 23 | $376 |
| ABBVIE INC. | 14 | $334 |
| Globus Medical, Inc. | 10 | $261 |
| TerSera Therapeutics LLC | 4 | $116 |
| Virtus Pharmaceuticals LLC | 4 | $102 |
| Impel Pharmaceuticals LLC | 3 | $65 |
| Averitas Pharma Inc. | 1 | $58 |
| Ipsen Biopharmaceuticals, Inc | 2 | $57 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $56 |
Products named: Evoke, Belbuca, QULIPTA, Senza, Prialt, UBRELVY, LEVORPHANOL TARTRATE, Vyrsa V1.
Industry payments across CA — which companies pay providers there.
